Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 122

1.

A prospective study of relative telomere length and postmenopausal breast cancer risk.

De Vivo I, Prescott J, Wong JY, Kraft P, Hankinson SE, Hunter DJ.

Cancer Epidemiol Biomarkers Prev. 2009 Apr;18(4):1152-6. doi: 10.1158/1055-9965.EPI-08-0998. Epub 2009 Mar 17.

2.

Association of leukocyte telomere length with breast cancer risk: nested case-control findings from the Shanghai Women's Health Study.

Qu S, Wen W, Shu XO, Chow WH, Xiang YB, Wu J, Ji BT, Rothman N, Yang G, Cai Q, Gao YT, Zheng W.

Am J Epidemiol. 2013 Apr 1;177(7):617-24. doi: 10.1093/aje/kws291. Epub 2013 Feb 25.

3.

Telomere length in blood cells and breast cancer risk: investigations in two case-control studies.

Zheng YL, Ambrosone C, Byrne C, Davis W, Nesline M, McCann SE.

Breast Cancer Res Treat. 2010 Apr;120(3):769-75. doi: 10.1007/s10549-009-0440-z. Epub 2009 Jun 19.

4.

A prospective study of endogenous estrogens and breast cancer in postmenopausal women.

Toniolo PG, Levitz M, Zeleniuch-Jacquotte A, Banerjee S, Koenig KL, Shore RE, Strax P, Pasternack BS.

J Natl Cancer Inst. 1995 Feb 1;87(3):190-7.

PMID:
7707406
5.

Telomere length in peripheral blood and breast cancer risk in a prospective case-cohort analysis: results from the Sister Study.

Kim S, Sandler DP, Carswell G, De Roo LA, Parks CG, Cawthon R, Weinberg CR, Taylor JA.

Cancer Causes Control. 2011 Jul;22(7):1061-6. doi: 10.1007/s10552-011-9778-8. Epub 2011 Jun 5.

6.

Premenopausal endogenous steroid hormones and breast cancer risk: results from the Nurses' Health Study II.

Fortner RT, Eliassen AH, Spiegelman D, Willett WC, Barbieri RL, Hankinson SE.

Breast Cancer Res. 2013 Mar 6;15(2):R19. doi: 10.1186/bcr3394.

7.

Telomere length and genetic variation in telomere maintenance genes in relation to ovarian cancer risk.

Terry KL, Tworoger SS, Vitonis AF, Wong J, Titus-Ernstoff L, De Vivo I, Cramer DW.

Cancer Epidemiol Biomarkers Prev. 2012 Mar;21(3):504-12. doi: 10.1158/1055-9965.EPI-11-0867. Epub 2012 Jan 20.

8.

Plasma sex steroid hormone levels and risk of breast cancer in postmenopausal women.

Hankinson SE, Willett WC, Manson JE, Colditz GA, Hunter DJ, Spiegelman D, Barbieri RL, Speizer FE.

J Natl Cancer Inst. 1998 Sep 2;90(17):1292-9.

PMID:
9731736
9.

Endogenous estrogen, androgen, and progesterone concentrations and breast cancer risk among postmenopausal women.

Missmer SA, Eliassen AH, Barbieri RL, Hankinson SE.

J Natl Cancer Inst. 2004 Dec 15;96(24):1856-65.

PMID:
15601642
10.

Telomere length in peripheral leukocyte DNA and gastric cancer risk.

Hou L, Savage SA, Blaser MJ, Perez-Perez G, Hoxha M, Dioni L, Pegoraro V, Dong LM, Zatonski W, Lissowska J, Chow WH, Baccarelli A.

Cancer Epidemiol Biomarkers Prev. 2009 Nov;18(11):3103-9. doi: 10.1158/1055-9965.EPI-09-0347. Epub 2009 Oct 27.

11.

No association between telomere length in peripheral blood leukocytes and the risk of nonmelanoma skin cancer.

Liang G, Qureshi AA, Guo Q, De Vivo I, Han J.

Cancer Epidemiol Biomarkers Prev. 2011 May;20(5):1043-5. doi: 10.1158/1055-9965.EPI-11-0072. Epub 2011 Feb 25.

12.

No association between TERT-CLPTM1L single nucleotide polymorphism rs401681 and mean telomere length or cancer risk.

Pooley KA, Tyrer J, Shah M, Driver KE, Leyland J, Brown J, Audley T, McGuffog L, Ponder BA, Pharoah PD, Easton DF, Dunning AM.

Cancer Epidemiol Biomarkers Prev. 2010 Jul;19(7):1862-5. doi: 10.1158/1055-9965.EPI-10-0281. Epub 2010 Jun 22.

13.

Telomere length in peripheral blood leukocytes is associated with risk of colorectal cancer in Chinese population.

Qin Q, Sun J, Yin J, Liu L, Chen J, Zhang Y, Li T, Shi Y, Wei S, Nie S.

PLoS One. 2014 Feb 3;9(2):e88135. doi: 10.1371/journal.pone.0088135. eCollection 2014.

14.

Short telomere length and breast cancer risk: a study in sister sets.

Shen J, Terry MB, Gurvich I, Liao Y, Senie RT, Santella RM.

Cancer Res. 2007 Jun 1;67(11):5538-44.

15.

Chromosome 9 arm-specific telomere length and breast cancer risk.

Zheng YL, Loffredo CA, Shields PG, Selim SM.

Carcinogenesis. 2009 Aug;30(8):1380-6. doi: 10.1093/carcin/bgp151. Epub 2009 Jun 17.

16.

Telomere length, oxidative damage, antioxidants and breast cancer risk.

Shen J, Gammon MD, Terry MB, Wang Q, Bradshaw P, Teitelbaum SL, Neugut AI, Santella RM.

Int J Cancer. 2009 Apr 1;124(7):1637-43. doi: 10.1002/ijc.24105.

17.

Telomere length in prospective and retrospective cancer case-control studies.

Pooley KA, Sandhu MS, Tyrer J, Shah M, Driver KE, Luben RN, Bingham SA, Ponder BA, Pharoah PD, Khaw KT, Easton DF, Dunning AM.

Cancer Res. 2010 Apr 15;70(8):3170-6. doi: 10.1158/0008-5472.CAN-09-4595.

18.

Circulating 2-hydroxy- and 16alpha-hydroxy estrone levels and risk of breast cancer among postmenopausal women.

Eliassen AH, Missmer SA, Tworoger SS, Hankinson SE.

Cancer Epidemiol Biomarkers Prev. 2008 Aug;17(8):2029-35. doi: 10.1158/1055-9965.EPI-08-0262.

19.

Breast cancer survival is associated with telomere length in peripheral blood cells.

Svenson U, NordfjÀll K, Stegmayr B, Manjer J, Nilsson P, Tavelin B, Henriksson R, Lenner P, Roos G.

Cancer Res. 2008 May 15;68(10):3618-23. doi: 10.1158/0008-5472.CAN-07-6497.

20.

Association between cutaneous nevi and breast cancer in the Nurses' Health Study: a prospective cohort study.

Zhang M, Zhang X, Qureshi AA, Eliassen AH, Hankinson SE, Han J.

PLoS Med. 2014 Jun 10;11(6):e1001659. doi: 10.1371/journal.pmed.1001659. eCollection 2014 Jun. Erratum in: PLoS Med. 2015 Mar;12(3):e1001797.

Supplemental Content

Support Center